Alexander Fleming, Chairman, Chief Medical Officer and Founder

Co-Founder of Kinexum LLC – a leading strategic consulting organization in the cardiometabolic space. Sits on over a dozen clinical advisory boards for major pharma and biotech co’s

FDA – 12 years, Head of Metabolic Group including diabetes, approved first statin, growth hormones, and all diabetes drugs in the 1990’s. Represented FDA at international forums. Led professional education at CDER, FDA

CRO – 3 years Chief Scientific Officer, conducted drug trials worldwide,
CRO sold to United Healthcare

Emory MD and residency, fellowships at Vanderbilt in endocrinology
and NIH in metabolism


Lisa Jansa, CEO and Founder

Co-Founder Of Kinexum LLC – Diabetes market consulting leader

Baxter Diagnostics – 13 years in marketing/sales/national accounts

Spectral Diagnostics – 3 years, VP Marketing responsible for strategy,
product development, and clinical trials

Boston Medical – 3 years, VP Sales responsible for strategy and
operations for med device start-up